Factors influencing behavioral cough suppression therapy in children with nonspecific chronic cough
Pediatric Pulmonology · 2023
DOI: 10.1002/ppul.26677 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pediatric Pulmonology, 2023. Verfasst von Robert Brinton Fujiki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of Wisconsin - Madison, Madison, Wisconsin, USA. Hauptthemen laut MEDLINE: Asthma, Gastroesophageal Reflux. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDCD NIH HHS, NIH HHS, National Institutes of Health.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Behavioral cough suppression therapy (BCST) with a speech–language pathologist is a common treatment for chronic nonspecific cough (a.k.a., tic cough) in children. Yet, the outcomes and duration of pediatric BCST have eluded formal investigation. This study examined whether BCST improves cough in children with nonspecific cough and factors that predict the course of treatment. Additionally, the cough characteristics and comorbidities associated with the condition were examined.
Methods
A retrospective, observational cohort design was utilized. Cough characteristics, medical history, and BCST treatment details and outcomes for 151 children were extracted from the electronic medical record of a large outpatient pediatric otolaryngology clinic.
Results
Cough was dry and onset unaccompanied by illness in most cases. Roughly half of patients reported gradual onset and cough proceeded by tickle. On average, patients experienced symptoms for 19 months (SD = 20.09) before diagnosis. Rates of comorbid General Anxiety Disorder were elevated compared to pediatric norms. Additionally, high rates of asthma (22.1%), reflux (62.3%), and disordered sleep breathing (19.2%) were observed. Common findings on laryngoscopy included interarytenoid edema and erythema. Vocal fold changes were observed in 22.9% of children. BCST reduced cough in 92.5% of patients following an average of 1.7 sessions. Comorbid behavioral health diagnoses ( p = 0.013) or induced laryngeal obstruction symptoms ( p = 0.025) were significant predictors of increased therapy sessions. Cough proceeded by tickle significantly predicted fewer sessions in therapy ( p = 0.011).
Interpretation
Although randomized clinical trials are needed, these data suggest that BCST is a low‐risk, effective treatment for children with nonspecific cough.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, University of Wisconsin - Madison, Madison, Wisconsin, USA.
- Department of Otolaryngology-Head & Neck Surgery, University of Utah, Salt Lake City, Utah, USA.
- Department of Communication Sciences & Disorders, University of Utah, Salt Lake City, Utah, USA.
- Department of Psychiatry - Child and Adolescent Division, University of Utah School of Medicine, Salt Lake City, Utah, USA.
ORCID-Profile: Robert Brinton Fujiki, Miranda L Wright, Amanda E Fujiki, Susan L Thibeault
Förderung
- NIDCD NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Fujiki, R. B., Wright, M. L., Fujiki, A. E., & Thibeault, S. L. (2023). Factors influencing behavioral cough suppression therapy in children with nonspecific chronic cough. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26677
Vancouver
Fujiki RB, Wright ML, Fujiki AE, Thibeault SL. Factors influencing behavioral cough suppression therapy in children with nonspecific chronic cough. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26677
BibTeX
@article{Fujiki2023,
author = {Fujiki, Robert Brinton and Wright, Miranda L and Fujiki, Amanda E and Thibeault, Susan L},
title = {Factors influencing behavioral cough suppression therapy in children with nonspecific chronic cough},
journal = {Pediatric Pulmonology},
year = {2023},
doi = {10.1002/ppul.26677}
}
EUVIMED